CVS Health Corporation Announces Quarterly Dividend of $0.67 (NYSE:CVS)

CVS Health Corporation (NYSE:CVS) declared a quarterly dividend on Wednesday, March 18th. Shareholders of record on Thursday, April 23rd will be paid a dividend of 0.665 per share by the pharmacy operator on Monday, May 4th. This represents a c) annualized dividend and a yield of 3.6%. The ex-dividend date of this dividend is Thursday, April 23rd.

CVS Health has raised its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 4 consecutive years. CVS Health has a payout ratio of 37.7% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect CVS Health to earn $6.77 per share next year, which means the company should continue to be able to cover its $2.66 annual dividend with an expected future payout ratio of 39.3%.

CVS Health Price Performance

CVS opened at $73.03 on Thursday. The company has a market capitalization of $92.91 billion, a P/E ratio of 52.92, a PEG ratio of 0.78 and a beta of 0.49. The company has a 50-day moving average of $77.83 and a 200-day moving average of $77.83. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. CVS Health has a 1-year low of $58.35 and a 1-year high of $85.15.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion during the quarter, compared to the consensus estimate of $103.67 billion. During the same period last year, the firm earned $1.19 earnings per share. The company’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities analysts expect that CVS Health will post 5.89 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Argus reduced their price objective on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research note on Wednesday, January 28th. Cantor Fitzgerald reissued an “overweight” rating on shares of CVS Health in a report on Wednesday, December 10th. Bank of America decreased their price target on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating for the company in a report on Tuesday, January 27th. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price objective (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Truist Financial set a $100.00 target price on shares of CVS Health in a report on Wednesday, December 10th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $95.05.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.